Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Toray and Fujisawa to codevelop TRK-820 in Europe

Feb. 3, 2003

MBI-594AN enters phase IIb for treatment of acne

Jan. 31, 2003

Naltrexone well tolerated and effective in pruritus caused by cholestasis

Jan. 28, 2003

Two courses of alefacept evaluated in patients with chronic plaque psoriasis

Jan. 24, 2003

QRX-101 phase II trial in psoriasis cleared to begin

Jan. 24, 2003

Efficacy of TAK-427 in experimental model of atopic dermatitis

Jan. 23, 2003

Positive phase III results for Enbrel in psoriasis

Jan. 21, 2003

Tacrolimus reported safe and effective in chronic actinic dermatitis

Jan. 20, 2003

Shire licenses Solaraze rights in Australia and certain Pacific Rim territories

Jan. 17, 2003

Access licenses amlexanox to Zambon

Jan. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...